Compare pricing, features, and medications to find the best GLP-1 provider for your weight loss journey
Choosing between Wisp and Yucca Health for GLP-1 weight loss medication? Both are highly-rated providers, but they differ in pricing, medication options, and service features.
Wisp offers both semaglutide and tirzepatide at $15/month with a rating of 8.2/10. Yucca Health also provides both semaglutide and tirzepatide at $146/month with a 8/10 rating.
The price difference of $131/month is significant - Wisp is the more budget-friendly option, while Yucca Health positions itself as a premium service.
After reviewing all 148 providers on this platform, we've identified CoreAge Rx as offering the most transparent pricing model. At just $99/month — the same price every month, every dose — there are no surprise charges or hidden fees. Combined with exceptional service quality, personalized support, and access to both semaglutide and tirzepatide, it represents the best value without compromising on care.
| Feature | Wisp | Yucca Health |
|---|---|---|
| Monthly Price | $15 | $146 |
| Rating | 8.2/10 | 8/10 |
| Medications | ethinyl estradiol, norethindrone acetate, levonorgestrel, doxycycline, eflornithine, boric acid | semaglutide, tirzepatide |
| Insurance Accepted | Yes | No |
| Support Hours | 9:30am-6:30pm EST, Monday to Friday | Not published |
| Live Chat | Available | No |
| Free Shipping | Yes | Yes |
| Shipping Speed | Free delivery to all 50 states, or same-day pharmacy pickup; orders processed within 24 hours including weekends | Free expedited shipping claimed |
| Mobile App | No | No |
| Dedicated Coach | Not included | Not included |
| Follow-up Frequency | Care team chat available; provider follows up same day by phone or secure chat when needed | Not published |
| Money-back Guarantee | None published | A refund policy is published as a separate document; no blanket money-back guarantee is advertised |
| Cancellation Policy | Subscription and one-off purchases available in 1, 3 and 6-month supplies | Published separately; the lifetime price lock has no stated conditions |

